Bone Biologics Corporation

NASDAQ: BBLGW · Real-Time Price · USD
20.20
4.60 (29.49%)
At close: Apr 23, 2025, 1:43 PM

Bone Biologics Revenue

Bone Biologics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Bone Biologics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
2
Market Cap
2.29M

Revenue Chart

Created with Highcharts 11.4.30000000000202020212022202320240

Bone Biologics Revenue - Annual

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.